Herein, we hypothesized that the presence of TLR2, TLR4 and TLR9 variants affect gut homeostasis resulting in impairment of TLRs activation, thus leading to inflammation and CRC development and progression. This evidence concerns the gene TLR2 and colorectal carcinoma.